{
    "organizations": [],
    "uuid": "32cafcfa017fbd2055f24f6e05dfd6f6157e117b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pfizer-q4-worldwide-total-lyrica-r/brief-pfizer-q4-worldwide-total-lyrica-rev-1130-mln-idUSFWN1PP10P",
    "ord_in_thread": 0,
    "title": "BRIEF-Pfizer Q4 Worldwide Total Lyrica Rev $‍​1,130 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Pfizer Inc:\n* PFIZER INC QTRLY WORLDWIDE TOTAL LYRICA REVENUE $‍​1,130 MILLION VERSUS $1,057 MILLION\n* PFIZER INC QTRLY WORLDWIDE PREVNAR FAMILY REVENUE $‍​1,533 MILLION VERSUS $1,416 MILLION\n* PFIZER INC QTRLY WORLDWIDE IBRANCE REVENUE $716 MILLION VERSUS $643 MILLION\n* PFIZER INC QTRLY WORLDWIDE LIPITOR REVENUE $574 MILLION VERSUS $464 MILLION Source text: ( bit.ly/2rQoNxQ ) Further company coverage:\n ",
    "published": "2018-01-30T20:12:00.000+02:00",
    "crawled": "2018-01-31T16:28:28.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "pfizer",
        "inc",
        "pfizer",
        "inc",
        "qtrly",
        "worldwide",
        "total",
        "lyrica",
        "revenue",
        "million",
        "versus",
        "million",
        "pfizer",
        "inc",
        "qtrly",
        "worldwide",
        "prevnar",
        "family",
        "revenue",
        "million",
        "versus",
        "million",
        "pfizer",
        "inc",
        "qtrly",
        "worldwide",
        "ibrance",
        "revenue",
        "million",
        "versus",
        "million",
        "pfizer",
        "inc",
        "qtrly",
        "worldwide",
        "lipitor",
        "revenue",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "company",
        "coverage"
    ]
}